C07H 19/12
Triazine radicals
C07H19/12 (Triazine radicals) appears on 139 US grants and 180 published applications in this corpus.
Search patents in C07H- Granted patents
- 139
- Published applications
- 180
- Assignees
- 109
- Inventors
- 359
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 2 |
| 2002 | 3 | 4 |
| 2003 | 2 | 6 |
| 2004 | 1 | 8 |
| 2005 | 7 | 9 |
| 2006 | 5 | 16 |
| 2007 | 5 | 10 |
| 2008 | 3 | 4 |
| 2009 | 8 | 8 |
| 2010 | 9 | 12 |
| 2011 | 3 | 4 |
| 2012 | 5 | 6 |
| 2013 | 8 | 9 |
| 2014 | 3 | 11 |
| 2015 | 7 | 8 |
| 2016 | 9 | 8 |
| 2017 | 5 | 6 |
| 2018 | 5 | 4 |
| 2019 | 7 | 10 |
| 2020 | 3 | 3 |
| 2021 | 6 | 9 |
| 2022 | 2 | 5 |
| 2023 | 3 | 8 |
| 2024 | 1 | 7 |
| 2025 | 6 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Alpha-D-galactopyranoside derivatives3 Jun 2025US 12,319,672 B2Idorsia Pharmaceuticals Ltd
- Spiro derivatives of Alpha-D-galactopyranosides27 May 2025US 12,312,362 B2Idorsia Pharmaceuticals Ltd
- Hydroxyheterocycloalkane-carbamoyl derivatives20 May 2025US 12,304,902 B2Idorsia Pharmaceuticals Ltd
- 2-hydroxycycloalkane-1-carbamoyl6 May 2025US 12,291,519 B2Idorsia Pharmaceuticals Ltd
- Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives6 May 2025US 12,291,520 B2Idorsia Pharmaceuticals Ltd
- Method for preparing 4'-thio-5-aza-2'-deoxycytidine20 Nov 2025US 2025/0353838 A1Pinotbio, Inc.
- Alpha-d-galactopyranoside derivatives14 Aug 2025US 2025/0257056 A1Idorsia Pharmaceuticals Ltd
- Compounds and methods for treating disease8 May 2025US 2025/0145654 A1ROME Therapeutics, Inc.
- Synthesis of Protected 3'-amino Nucleoside Monomers12 Sep 2024US 2024/0300992 A1Geron Corporation
- Novel universal anti-rna virus agents8 Aug 2024US 2024/0262857 A1
Most cited
By later US patents
- Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression597US 5,614,617 AIsis Pharmaceuticals, Inc. · 1997
- Nucleic acid analysis techniques405US 6,344,316 B12002
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase223US 7,125,855 B2Merck & Co., Inc. · 2006
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus217US 6,777,395 B2Isis Pharmaceuticals, Inc. · 2004
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase146US 7,202,224 B2Isis Pharmaceuticals, Inc. · 2007